Fate Therapeutics (FATE) Operating Margin Growth (5y) (2017 - 2026)
Fate Therapeutics (FATE) Operating Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -212,568.00 |
| Dec 31, 2025 | -232,612.00 |
| Sep 30, 2025 | -157,851.00 |
| Jun 30, 2025 | -141,325.00 |
| Mar 31, 2025 | -116,262.00 |
| Dec 31, 2024 | -228,203.00 |
| Sep 30, 2024 | -58,740.00 |
| Jun 30, 2024 | 18,923.00 |
| Mar 31, 2024 | -187,606.00 |
| Dec 31, 2023 | -186,055.00 |
| Sep 30, 2023 | -101,091.00 |
| Jun 30, 2023 | -479,683.00 |
| Mar 31, 2023 | 132,131.00 |
| Dec 31, 2022 | 104,698.00 |
| Sep 30, 2022 | 43,113.00 |
| Jun 30, 2022 | 48,470.00 |
| Mar 31, 2022 | 56,648.00 |
| Dec 31, 2021 | 33,880.00 |
| Sep 30, 2021 | 43,365.00 |
| Jun 30, 2021 | 43,057.00 |